Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
34
YMAB Quote, Financials, Valuation and Earnings
Last price:
$4.33
Seasonality move
:
-4.07%
Day range:
$4.20 - $4.39
52-week range:
$3.55 - $16.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.19x
P/B ratio:
2.20x
Volume:
181.7K
Avg. volume:
183.4K
1-year change:
-66.74%
Market cap:
$197M
Revenue:
$87.7M
EPS (TTM):
-$0.64
Earnings Data
Next earnings date for YMAB
Aug 12
2025
Most recent earnings per share
-$0.12
Beat by $0.08
(May 13/2025)
Consensus Estimate
-$0.20
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
YMAB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $21M | -- | -- | -$0.26 | -- |
| 08/12/2025 | Q2 | $18.4M | -- | -- | -$0.25 | -- |
| 05/13/2025 | Q1 | $19.6M | $20.9M | -$0.12 | -$0.20 | $0.08 |
| 03/04/2025 | Q4 | $26.7M | $26.5M | -$0.15 | -$0.13 | -$0.02 |
| 11/08/2024 | Q3 | $23.3M | $18.5M | -$0.16 | -$0.15 | -$0.01 |
| 08/12/2024 | Q2 | $23M | $22.8M | -$0.21 | -$0.12 | -$0.09 |
| 05/07/2024 | Q1 | $22.2M | $19.9M | -$0.15 | -$0.13 | -$0.02 |
| 02/29/2024 | Q4 | $21M | $23.4M | -$0.02 | -$0.18 | $0.16 |
| 11/13/2023 | Q3 | -- | -- | -$0.18 | -$0.18 | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.14 | -$0.24 | $0.10 |
| 05/08/2023 | Q1 | -- | -- | -$0.15 | -$0.31 | $0.16 |
| 03/30/2023 | Q4 | -- | -- | $0.03 | -$0.41 | $0.44 |
| 11/07/2022 | Q3 | -- | -- | -$0.63 | -$0.70 | $0.07 |
| 08/08/2022 | Q2 | -- | -- | -$0.94 | -$0.65 | -$0.29 |
| 05/09/2022 | Q1 | -- | -- | -$0.64 | -$0.67 | $0.03 |
| 02/24/2022 | Q4 | -- | -- | -$0.85 | -$0.69 | -$0.16 |
| 11/04/2021 | Q3 | -- | -- | -$0.66 | -$0.58 | -$0.08 |
| 08/05/2021 | Q2 | -- | -- | -$0.53 | -$0.64 | $0.11 |
| 05/06/2021 | Q1 | -- | -- | $0.75 | $0.62 | $0.13 |
| 02/25/2021 | Q4 | -- | -- | -$0.48 | -$0.54 | $0.06 |
| 11/05/2020 | Q3 | -- | -- | -$0.82 | -$0.77 | -$0.05 |
| 08/06/2020 | Q2 | -- | -- | -$1.01 | -$0.66 | -$0.35 |
| 05/07/2020 | Q1 | -- | -- | -$0.66 | -$0.61 | -$0.05 |
| 03/12/2020 | Q4 | -- | -- | -$0.61 | -$0.65 | $0.04 |
| 11/13/2019 | Q3 | -- | -- | -$0.70 | -$0.54 | -$0.16 |
| 08/14/2019 | Q2 | -- | -- | -$0.53 | -$0.49 | -$0.04 |
| 05/10/2019 | Q1 | -- | -- | -$0.47 | -$0.39 | -$0.08 |
| 03/22/2019 | Q4 | -- | -- | -$0.42 | -$0.34 | -$0.08 |
| 11/13/2018 | Q3 | -- | -- | -$0.42 | -$0.36 | -$0.06 |
Y-mAbs Therapeutics Earnings Questions
-
How Much did Y-mAbs Therapeutics Generate in Revenue Last Quarter?
Y-mAbs Therapeutics reported $20.9M worth of top line sales in its most recent quarter.
-
Did Y-mAbs Therapeutics Beat Earnings Last Quarter?
Y-mAbs Therapeutics announced earnings per share of -$0.12 which represents a beat of analyst forecast a -$0.20 per share.
-
Is Y-mAbs Therapeutics Profitable?
Y-mAbs Therapeutics reported $17.9M that represents $0.40 per share over the last quarter.
-
What is the Analyst Consensus for Y-mAbs Therapeutics EPS Next Year?
Y-mAbs Therapeutics's earnings are forecast to decrease from -$0.67 per share to -$0.58 per share next year representing a decrease of -37.61%.
-
When is Y-mAbs Therapeutics's Earnings Date?
Y-mAbs Therapeutics's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
